The UCI today has announced that ISN's Patrick Schelling;
Team's response:"has been sanctioned with a period of ineligibility of four months for a non-intentional anti-doping rule violation. The matter arises as a result of an Adverse Analytical Finding (AAF) for Terbutaline* in a sample collected on 24 February 2020. In accordance with the World Anti-Doping Code (WADC) and the UCI Anti-Doping Regulations (UCI ADR), the period of ineligibility starts on 18 May 2020 and is effective until 17 September 2020. The rider has also been disqualified from all competitive results obtained at the Tour of Rwanda 2020.
Statement from the rider:“We are disappointed that our rider Patrick Schelling had an Adverse Analytical Finding for an asthma medicine, in Tour of Rwanda of this year, that then resulted in four months of ineligibility. ISN was not aware that Mr. Schelling was taking this substance, as it was not declared to the team. We accept the sanction by the UCI, which was imposed in accordance with the Anti-Doping Rules. ISN will deal with this internally to ensure that such violations are not repeated.”
This is the same drug Simon Yates popped his positive for in 2016.“I have suffered from asthma since childhood. It was an unintentional mistake to use a non-allowed asthma spray, and I would like to apologize to the authorities, to the team, and to the whole cycling family. It has never been my intention to damage the image of cycling, I regret my wrongdoing and I take full responsibility for my error in judgment.”